Cardiovascular Tissue Engineering: Preclinical Validation to Bedside Application | Zendy

Cameron A. Best | Zendy; Ekene Onwuka | Zendy; Victoria K. Pepper | Zendy; Malik Sams | Zendy; Jake Breuer | Zendy; Christopher K. Breuer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cardiovascular Tissue Engineering: Preclinical Validation to Bedside Application

Author(s) -

Cameron A. Best,

Ekene Onwuka,

Victoria K. Pepper,

Malik Sams,

Jake Breuer,

Christopher K. Breuer

Publication year - 2015

Publication title -

physiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.14

H-Index - 125

eISSN - 1548-9213

pISSN - 1548-9221

DOI - 10.1152/physiol.00018.2015

Subject(s) - tissue engineering , medicine , biomaterial , biomedical engineering , pathology , intensive care medicine

Advancements in biomaterial science and available cell sources have spurred the translation of tissue-engineering technology to the bedside, addressing the pressing clinical demands for replacement cardiovascular tissues. Here, the in vivo status of tissue-engineered blood vessels, heart valves, and myocardium is briefly reviewed, illustrating progress toward a tissue-engineered heart for clinical use.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research